AB Science fournit un résumé de la conférence web qui s’est tenue le 5 juin 2019

NEXT STORY
Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019
PREV STORY
Emergent BioSolutions kündigt FDA-Zulassung für Änderung bei Lagerbedingungen und Produktionsverlagerungen für seinen Cholera-Impfstoff an
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis announces new Mayzent® (siponimod) data show sustained effect in delaying disability for up to five years in patients with secondary progressive multiple sclerosis (SPMS)

author_avatar
NASDAQ Market News

EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development

author_avatar
NASDAQ Market News

Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News